Sugimoto S, Puddu P E, Monti F, Dawodu A A, del Monte F, Schiariti M, Campa P P, Marino B
Department of Cardiac Surgery, University of Rome La Sapienza, Italy.
J Mol Cell Cardiol. 1995 Sep;27(9):1867-81. doi: 10.1016/0022-2828(95)90010-1.
The hypothesis that nicorandil might enhance myocardial protection due to cold St Thomas' Hospital (STH) solution ([K+]o 16 mmol/l) through opening of cardiac KATP channels was assessed in isometrically contracting guinea-pig papillary muscles submitted to 120 min of cardioplegic hypoxia followed by 60 min of normothermic reoxygenation. Right ventricular papillary muscles were paced (2 ms, 4 mA) in an organ bath and superfused with oxygenated (O2 content 16 ml/l) Tyrode's solution (37 degrees C). The force-frequency relationship in the range 1600-300 ms cycle length (CL) was studied. Preparations were randomized to receive 120 min cold (20 degrees C), non-oxygenated (O2 content 5 ml/l) STH solution while continuously stimulated at 1600 ms CL, with: (1) saline (No-additive, n = 12); (2) DMSO 1% (Vehicle, n = 8); (3) nicorandil 1 mmol/l (n = 8); (4) nicorandil 1 mmol/l plus glibenclamide 1 mumol/l, the latter also given, before STH solution, in Tyrode's solution for 15 min (n = 8); (5) glibenclamide 1 mumol/l, also circulated, before STH solution, in Tyrode's solution for 15 min (n = 8); (6) nitroglycerin 100 mumol/l (n = 4); in addition, we studied: (7) STH solution with no-additive and no-pacing (n = 4); (8) cold Tyrode's in place of cold STH solution (n = 4). Inotropic state was investigated by measuring: (i) velocity of developed tension (DT), obtained by dividing DT by time to peak tension; (ii) percentage (from precardioplegia values) velocity changes of DT; (iii) log velocity of DT. Post-cardioplegic recovery of contractility (including force-frequency relationship) was assessed in all preparations: (a) 60 min after reoxygenation with Tyrode's solution; (b) after further 15 min superfusion with the positive inotropic agent dobutamine (10 mumol/l). In parallel experiments, action potential duration (APD) 50% changes induced by nicorandil or glibenclamide plus nicorandil in spontaneously beating atrial (n = 4) or electrically driven (1600 ms CL) ventricular (n = 8) tissues during 10 min of STH solution were investigated. Based on force-frequency relationship, at 60 min reoxygenation, in absence of cardioplegia, the lowest recovery of myocardial contractility was seen (stunning). In STH solution, there was moderate to severe stunning, which was unaffected by removing pacing during cardioplegia, or by vehicle or nitroglycerin. In contrast, nicorandil improved recovery of contractility (F = 3.01, P = 0.0106). After dobutamine, nicorandil preparations showed the highest positive inotropic response, which was completely offset by glibenclamide (F = 3.47, P = 0.0046).(ABSTRACT TRUNCATED AT 400 WORDS)
在等长收缩的豚鼠乳头肌中,研究了尼可地尔是否通过开放心脏KATP通道增强冷St Thomas' Hospital(STH)溶液([K⁺]o 16 mmol/l)的心肌保护作用。将乳头肌置于器官浴中,以2 ms、4 mA起搏,并用含氧(O₂含量16 ml/l)的台氏液(37℃)灌流。研究了1600 - 300 ms心动周期长度(CL)范围内的力-频率关系。将标本随机分为接受120分钟冷(20℃)、无氧(O₂含量5 ml/l)STH溶液组,同时在1600 ms CL持续刺激,分组如下:(1)生理盐水(无添加剂,n = 12);(2)1%二甲亚砜(溶媒,n = 8);(3)1 mmol/l尼可地尔(n = 8);(4)1 mmol/l尼可地尔加1 μmol/l格列本脲,后者在给予STH溶液前也在台氏液中孵育15分钟(n = 8);(5)1 μmol/l格列本脲,在给予STH溶液前也在台氏液中孵育15分钟(n = 8);(6)100 μmol/l硝酸甘油(n = 4);此外,还研究了:(7)无添加剂且不起搏的STH溶液(n = 4);(8)冷台氏液代替冷STH溶液(n = 4)。通过测量以下指标研究心肌收缩力状态:(i)张力发展速度(DT),通过DT除以达到峰值张力的时间获得;(ii)DT速度变化的百分比(相对于停搏前值);(iii)DT的对数速度。在所有标本中评估停搏后收缩力的恢复(包括力-频率关系):(a)用台氏液复氧60分钟后;(b)用正性肌力药物多巴酚丁胺(10 μmol/l)再灌流15分钟后。在平行实验中,研究了在10分钟STH溶液期间,尼可地尔或格列本脲加尼可地尔对自发搏动的心房(n = 4)或电驱动(1600 ms CL)的心室(n = 8)组织动作电位持续时间(APD)50%变化的影响。基于力-频率关系,在复氧60分钟时,在无停搏的情况下,观察到心肌收缩力恢复最低(顿抑)。在STH溶液中,存在中度至重度顿抑,停搏期间去除起搏或使用溶媒或硝酸甘油对此无影响。相比之下,尼可地尔改善了收缩力恢复(F = 3.01,P = 0.0106)。多巴酚丁胺处理后,尼可地尔组显示出最高的正性肌力反应,这被格列本脲完全抵消(F = 3.47,P = 0.0046)。(摘要截短至400字)